Peptide formulation

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 12, 530303, 530324, 424409, 424465, 424498, A61K 3800

Patent

active

060081872

ABSTRACT:
The present invention is directed to a pharmaceutical formulation of a therapeutic polypeptide together with a permeation-enhancing mixture of sodium salicylate and an oil to provide enhanced absorption of the polypeptide through the wall of the gastrointestinal tract, and particularly of the colon, after oral administration, the amount of oil being from about 10 wt % to about 30 wt %, preferably from about 15 wt % to about 25 wt %, of the total formulation and the amount of sodium salicylate being from about 70 wt % to about 90 wt %, preferably from about 75 wt % to about 85 wt %, of the total formulation. The polypeptide may be non-lyophilized. The pharmaceutical formulation is characterized as a solid, which provides a convenient and improved format for handling and storage and for the preparation of oral dosage forms (such as pills, capsules and delivery vessels) containing a homogeneous mixture of ingredients.

REFERENCES:
patent: 3867519 (1975-02-01), Michaels
patent: 3873694 (1975-03-01), Kanig
patent: 3950521 (1976-04-01), Higuchi
patent: 4434159 (1984-02-01), Sekine
patent: 4470962 (1984-09-01), Kieth
patent: 4639435 (1987-01-01), Fujii
patent: 4681897 (1987-07-01), Brand
patent: 4702918 (1987-10-01), Ushimaru et al.
patent: 4745103 (1988-05-01), Oono
patent: 5013560 (1991-05-01), Stentz
patent: 5304377 (1994-04-01), Yamada
More, et al., International Journal of Pharmaceutics, 34 (1986) pp. 35-43, "Absorption Enhancement of Growth Hormone from the Gastrointestinal Tract of Rats".
Palin, et al., J. Pharm. Pharmacol, 1982, vol. 34, pp. 707-710, "The Effect of Oils on the Lymphatic Absorption of DDT".
Palin, et al., J. Pharm. Pharmacol, 1984, vol. 36, pp. 641-643, "The Effect of Different Oils on the Absorption of Probucol in the Rat".
Omran, et al., Pharm. Acta Helv., vol. 58, No. 8 (1983), pp. 237-140, "Bioavailability Studies on an Orally Administered, Oily Suspension of a Water Soluble Drug".
Illustrated Stedman's Medical Dictionary, 24th Ed., Williams and Wilkins, Los Angeles, 1982, p. 421.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Peptide formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptide formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptide formulation will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-2382453

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.